doi.org/10.1016/j.eururo.2014.06.038, hdl.handle.net/1765/83512
European Urology : Official Journal of the European Association of Urology
Department of Urology

van Soest, R.J, De Wit, R, & van Weerden, W.M. (2014). Re: Nader Al Nakouzi, Sylvestre le Moulec, Laurence Albigès, et al. Cabazitaxel Remains Active in Patients Progressing after Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies. Eur Urol. in press. http://dx.doi.org/10.1016/j.eururo.2014.04.015. European Urology : Official Journal of the European Association of Urology, 66(4). doi:10.1016/j.eururo.2014.06.038